Oklahoma Chiropractor Convicted of $30M Medicare Fraud Using Telemedicine Signatures

How a Chiropractor's Telemedicine Scam Diverted Millions from Medicare and TRICARE

A federal jury in Florida has convicted Mark Loftis, a 39-year-old chiropractor from Cushing, Oklahoma, of conspiracy to commit health care fraud and wire fraud in a scheme that attempted to steal over $30 million from Medicare, TRICARE, and the Civilian Health and Medical Program of the Department of Veterans Affairs (CHAMPVA). Court evidence showed Loftis paid more than $1 million to marketers who worked with call centers to coax elderly and disabled Americans into giving up their personal and insurance details.

Those details were then used to obtain signed orders for orthotic braces and continuous glucose monitors from telemedicine physicians and nurse practitioners who never examined, and often never spoke to, the patients. Loftis used the sham orders to submit fraudulent claims, ultimately collecting more than $8 million over three years. The scheme continued even as families complained that their elderly relatives—suffering from dementia and Alzheimer’s—had been targeted by high-pressure sales tactics.

Loftis also concealed a co-conspirator’s management role in his company and billed claims generated by other unenrolled medical suppliers. He faces up to 20 years in prison when sentenced on October 7, 2026. The Department of Justice’s newly created Fraud Division prosecuted the case, underscoring a White House push to eliminate fraud across federal benefit programs.

What the Loftis Verdict Says About Enforcement of Telehealth and Durable Medical Equipment Claims

Telemedicine Signatures Without Patient Contact Now a Clear Legal Line

The conviction draws a sharp boundary for the durable medical equipment (DME) sector: an order signed without a real patient-provider interaction is not a gray area; it is fraud. Loftis’s scheme relied entirely on telemedicine providers who either rubber-stamped requests or never spoke to the patient, a pattern that the Department of Justice and the HHS Office of Inspector General painted as a calculated exploitation of telehealth flexibilities. For legitimate telemedicine platforms, the verdict signals that documentation of a contemporaneous, interactive examination is no longer optional—it is a baseline for every prescription that leads to a federal claim.

A Braces-and-Glucose-Monitor Marketplace on Notice

Orthotic braces and continuous glucose monitors are high-volume, high-reimbursement categories frequently targeted in fraud schemes. The case reveals how call centers and purchased patient data can turn those products into a pipeline of false billings. Suppliers who rely on third-party marketers to generate leads will face intensified scrutiny from Medicare Administrative Contractors and the OIG. The verdict also reinforces the emerging forensic pattern that spikes in brace and CGM claims, especially from newly enrolled or shell companies, are red flags that payers and law enforcement are now tracking systematically.

The New DOJ Fraud Division Sets a Tougher Enforcement Tone

This prosecution was handled by the Justice Department’s Fraud Division, created in April 2026 and chaired by Vice President J.D. Vance’s Task Force to Eliminate Fraud. The division’s involvement elevates health care fraud from a routine OIG-driven administrative action to a high-priority criminal pursuit. Companies operating in the DME space should anticipate faster, more coordinated multi-agency investigations and criminal referrals where billing anomalies suggest intentional scheme-like behavior.

Compliance Steps for DME Suppliers and Payers After the Loftis Conviction

For DME suppliers and telemedicine platforms:

• Verify every order: Ensure that every telemedicine-signed order for braces, CGMs, or similar DME includes a documented, synchronous audio-video encounter. A signed order without a real-time exam is now a prosecutable red flag.
• Audit marketing channels: Review lead-generation and call-center partners for any practice that might be construed as purchasing patient data or using high-pressure sales on seniors and the cognitively impaired. Terminate any relationship that cannot demonstrate patient consent and genuine medical need.
• Benchmark claim patterns: Compare your DME billing volumes against last year’s baseline. Sudden surges in braces or CGM claims, particularly if they coincide with a new telemedicine vendor, should trigger an internal compliance review before CMS or a recovery auditor does.

For payers and Medicare Advantage plans:

• Scan for out-of-network DME spikes: Run analytics to detect anomalous billing from unenrolled or newly enrolled medical suppliers for the same product categories exploited in this case.
• Expect heightened OIG activity: HHS OIG has publicly linked this verdict to its broader enforcement strategy. Plan for more targeted audits of orthotic and CGM claims in 2026–2027.